Thomas Linn
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Clinical Biochemistry top 1%
- Advanced Glycation End Products research
Papers in
- Surgery 54
- Pancreatic function and diabetes 50
-
- Diabetes Management and Research 17
- Diabetes Treatment and Management 9
- Diet, Metabolism, and Disease 7
- Hormonal and reproductive studies 6
- Co-authors
- Reinhard G. Bretzel (30 shared papers)Burkhard Göke (1 shared paper)H. C. Fehmann (1 shared paper)John Eng (1 shared paper)Rüdiger Göke (1 shared paper)Michael Krause (1 shared paper)Harald Schmidt (1 shared paper)Klaus T. Preissner (6 shared papers)
- Journals
- PLoS ONE (5 papers)Metabolism (5 papers)Diabetologia (5 papers)Experimental and Clinical Endocrinology & Diabetes (4 papers)Diabetes (4 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Thomas Linn
117 papers receiving 4.3k citations
Thomas Linn's Hit Papers
Peers
Comparison fields: 5 of 128
- Endocrinology, Diabetes and Metabolism 1.4k
- Clinical Biochemistry 403
- Reproductive Medicine 297
- Surgery 1.2k
- Pharmaceutical Science 133
Countries citing papers authored by Thomas Linn
This map shows the geographic impact of Thomas Linn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Linn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Linn more than expected).
Fields of papers citing papers by Thomas Linn
This network shows the impact of papers produced by Thomas Linn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Linn. The network helps show where Thomas Linn may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Linn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. Hit paper breakdown → | 1993 | 715 |
| 2 | The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte Integrins Hit paper breakdown → | 2003 | 505 |
| 3 | 2008 | 240 | |
| 4 | Diabetes-induced hyperglycemia impairs male reproductive function: a systematic review Hit paper breakdown → | 2017 | 232 |
| 5 | 2000 | 187 | |
| 6 | 2011 | 170 | |
| 7 | 2005 | 136 | |
| 8 | 2005 | 134 | |
| 9 | 1983 | 91 | |
| 10 | 2003 | 89 | |
| 11 | 1996 | 75 | |
| 12 | 2006 | 69 | |
| 13 | 2004 | 57 | |
| 14 | 1996 | 57 | |
| 15 | 2013 | 55 | |
| 16 | 2002 | 51 | |
| 17 | 2019 | 48 | |
| 18 | 2013 | 46 | |
| 19 | 2017 | 45 | |
| 20 | 2003 | 44 |
About Thomas Linn
Thomas Linn is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism, Genetics, Molecular Biology and Physiology, having authored 119 papers that have together received 4.4k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (50 papers), Diabetes and associated disorders (30 papers), Diabetes Management and Research (17 papers), Diabetes Treatment and Management (9 papers), Diet and metabolism studies (8 papers), Diet, Metabolism, and Disease (7 papers), Hormonal and reproductive studies (6 papers) and Adipose Tissue and Metabolism (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.4k citations), Clinical Biochemistry (403 citations), Reproductive Medicine (297 citations), Surgery (1.2k citations) and Pharmaceutical Science (133 citations). Thomas Linn has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Reinhard G. Bretzel, Burkhard Göke, H. C. Fehmann, John Eng, Rüdiger Göke, Michael Krause, Harald Schmidt, Klaus T. Preissner, Darius Schneider and Constanze C. Maresch. Their work appears in journals such as PLoS ONE, Metabolism, Diabetologia, Experimental and Clinical Endocrinology & Diabetes and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.